Trial · NCT04514458
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Patients With Heart Failure With Reduced Ejection Fraction (HFrEF) With an Increase in Prescribed HFrEF Therapy | Assessed from the date of randomization to 30 days post-randomization | Assessed as an increase in the number of prescribed targeted evidence-based therapies for HFrEF, including beta-blockers, ACEi, ARBs, ARNIs, MRAs, and SGLT2is. |
| Secondary | Percentage of Patients on Beta Blockers | Assessed from the date of randomization to 30 days post-randomization | Assessed as the number of patients with prescribed beta blockers |
| Secondary | Percentage of Patients on ACE Inhibitors | Assessed from the date of randomization to 30 days post-randomization | Assessed as the number of patients with a prescribed ACEi |
| Secondary | Percentage of Patients on ARBs | Assessed from the date of randomization to 30 days post-randomization | Assessed as the number of patients with a prescribed ARB |
| Secondary | Percentage of Patients on ARNIs | Assessed from the date of randomization to 30 days post-randomization | Assessed as the number of patients with a prescribed ARNI |
| Secondary | Percentage of Patients on MRAs | Assessed from the date of randomization to 30 days post-randomization | Assessed as the number of patients with a prescribed MRA |
| Secondary | Percentage of Patients on SGLT2 Inhibitors | Assessed from the date of randomization to 30 days post-randomization | Assessed as the number of patients with a prescribed SGLT2i |
| Secondary | Rate of One-year All-cause Mortality | Assessed from the date of randomization to the date of death from any cause, up to 365 days post-randomization | Assessed as the number of patients who expired from randomization up to one year from any cause. |
| Secondary | Rate of 30-day Hospital Admission | Assessed from the date of randomization to the date of hospital admission, up to 30 days post-randomization | Number of participants with a hospitalization within 30 days of randomization |
| Secondary | Rate of 30-day All-cause Emergency Department Visits | Assessed from the date of randomization to the date of ED/ER admission, up to 30 days post-randomization | Number of participants with an emergency department visit within 30 days of randomization. |
| Secondary | Total Six-month Healthcare Costs | Assessed from the date of randomization to 6 months post-randomization | Assessed as total direct and indirect cost of patient care from randomization to 6 months post randomization. |
| Secondary | Percentage of Filled Prescriptions | Assessed 6 months post-randomization | Proportion of prescriptions filled as assessed by SureScripts |
| Secondary | Medication Dose of Any Prescribed Beta Blocker | Assessed at 6 months post-randomization | |
| Secondary | Medication Dose of Any Prescribed ACEi | Assessed at 6 months post-randomization | |
| Secondary | Medication Dose of Any Prescribed ARB | Assessed at 6 months post-randomization | |
| Secondary | Medication Dose of Any Prescribed ARNI | Assessed at 6 months post-randomization | |
| Secondary | Medication Dose of Any Prescribed MRA | Assessed at 6 months post-randomization | |
| Secondary | Medication Dose of Any Prescribed SGLT2 Inhibitor | Assessed at 6 months post-randomization |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04514458/registered